Gistem Research secures European Patent Protection for hUCESCs.
Gijón, Spain – 17 June 2019 – Gistem Research SL, a research driven company that is dedicated to the discovery and development of novel and innovative approaches derived from mesenchymal stem cells, has announced that it has been granted patent protection (Patent Number PCT/2014/053508) for their human Uterine Cervical Stem cell´s method and uses in Europe, one of the largest Biopharmaceutical markets in the world. This adds to patent protection also granted in Russia, Japan and Australia, strengthening the company’s growing portfolio globally.